Biodexa Pharmaceuticals Plc (BDRX)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Feb 24, 12:14
Biodexa Pharmaceuticals Cash from Financing (TTM) : 12.98M for June 30, 2025
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| NuCana Plc | 36.12M |
| Autolus Therapeutics Plc | 27.46M |
| Mereo BioPharma Group Plc | 0.0608M |
| Bicycle Therapeutics Plc | -2.030M |
| DBV Technologies SA | 118.28M |